Dublin, Aug. 02, 2023 (GLOBE NEWSWIRE) The "Venous Thromboembolism (VTE) Epidemiology Analysis and Forecast to 2032" report has been added to ResearchAndMarkets.com's offering.Epidemiologists forecast an increase in the diagnosed incident cases of VTE in the 7MM, from 1,469,547 cases in 2022 to 1,690,608 in 2032, at an annual growth rate (AGR) of 1.50%. The number of VTE attacks is forecast to grow from 1,602,747 in 2022, to 1,848,622 in 2032 in the 7MM, at an AGR of 1.53%. The publishing epi
Cancer patients with venous thromboembolism should preferentially be given direct oral anticoagulants over other drugs to reduce the risk of major complications, a recent analysis shows.
Two thirds of venous thromboembolism events came during neoadjuvant chemotherapy and might have been prevented with direct-acting oral anticoagulants, a new study suggests.
Public Release: 20-Sep-2017 Gunshot and stabbing victims more likely to die if transported to the trauma center by ambulance Johns Hopkins Medicine A new study finds that victims of gunshots and stabbings are significantly less likely to die if they're taken to the trauma center by a private vehicle than ground emergency medical services…
1. In this Markov modeling study, indefinite anticoagulation for first unprovoked venous thromboembolism (VTE) cost $16,014 more per person than discontinuation based on clinical guidelines. 2. Indefinite anticoagulation for first unprovoked VTE did not increase the number of quality-adjusted life-years (QALYs) per patient. Evidence Rating Level: 1 (Excellent) Study Rundown: VTE is estimated to have a